leisure time -WSS

leisure time

author：comprehensive 2025-10-01 01:51:07 - browse：22385

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Diversify hospital leadership teams to protect BIPOC patient health

focus

WSS

Travis Kelce and the trap of celebrity vaccine endorsements

Medicare must police algorithms in Medicare Advantage, Dems say

Medicare proceeds with plan to claw back hospital funds

After Sarepta trial failure, Duchenne families brace for more debate

White House calls on federal agencies to crack down on AI abuses

Brain injuries and the importance of a second opinion

hotspot

leisure time

leisure time

Medical records are filled with copy

Medicare proceeds with plan to claw back hospital funds

Medicare details structure of new drug price negotiation program

Just how powerful is the placebo effect?

The cancer drug shortage isn’t new — and neither are the solutions

HPV cancer vaccine study demonstrates efficacy

As demand for Covid shots wanes, Moderna seeks its next success

Victims of gun violence feel impacts long after bullet wound

How to save PrEP access — and even expand it

Prime Medicine says its gene editing passes test in monkeys

knowledge

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Inari Medical to buy amputation prevention company LimFlow

HPV cancer vaccine study demonstrates efficacy

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

FDA approves potent Eli Lilly obesity drug, Zepbound

Life sciences investors close nearly $6 billion in new funds

focus

leisure time

focus

explore